Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
HIGHMARK, INC.

2. Address

Address1
1800 CENTER STREET
 Address2
​
City
CAMP HILL
 State
PA
 Zip Code
17089
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Michael G. Warfel
​7173023978
​michael.warfel@highmark.com
5. Senate ID#
​18238-12
7. Client Name Self Check if client is a state or local government or instrumentality
​HIGHMARK, INC.
6. House ID#
​309760000
TYPE OF REPORT 8. Year
​2020
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​290,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Michael G. Warfel
 Date
4/20/2020 8:35:31 AM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Opioids; CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Biosimilars; Drug approval; Drug patents, generic drugs, Part D Reform, Biosimilars, Civica Rx

H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]

H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]

S.3013 - 116th Congress (2019-2020)
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Sponsor: Sen. Toomey, Pat [R-PA]

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Mike
Warfel
​
​
Greg
Englert
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Affordable Care Act (ACA); Affordability, ACA Regulations; ACA Stabilization; Health Reform; Risk Adjustment; Opioids; Marketplace Stability; Individual Market Reform; Health Care Costs; Transparency; Surprise billing, Prior Authorization; Negotiated rate disclosure; Consumer-facing app disclosures; Medicare for All; Medicare Buy-in; Public Option; NBPP (Notice Benefit and Payment Parameters), COVID-19 Response/Relief Packages

H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)

S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)

H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]

H.R.3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. DelBene, Suzan K. [D-WA-1]

H.R.2279 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Rep. Ruiz, Raul [D-CA-36]

S. 2546 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Sen. Lisa Murkowski (R-AK)

H.R. 5826 - 116th Congress - Second Session
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Richard Neal(D-MA-01)

S. 3548 - 116th Congress - Second Session
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. Mitch McConnell (R-KY)

H.R. 5800 - 116th Congress - Second Session
Ban Surprise Billing Act
Sponsor: Rep. Bobby Scott (D-VA-03)

H.R. 6201 - 116th Congress - Second Session
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey (D-NY-17)

H.R. 6311 - 116th Congress - Second Session
Care for COVID-19 Act
Sponsor: Rep. Raul Ruiz (D-CA-36)

H.R. 6299 - 116th Congress - Second Session
Rapid Coverage of COVID-19 Vaccine Act of 2020

H.R. 6173 - 116th Congress - Second Session
Covering Coronavirus Test Act of 2020
Sponsor: Rep. Diana DeGette (D-CO-01)

H.R. 6213 - 116th Congress - Second Session
No Cost for COVID-19 Testing Act
Sponsor: Rep. Frederica Wilson (D-FL-24)

H.R. 6222 - 116th Congress - Second Session
Ensuring Affordable COVID-19 Preventive Care Act of 2020
Sponsor: Rep. Jan Schakowsky (D-IL-09)

H.R. 6232 - 116th Congress - Second Session
To require the Secretary of Health and Human Services, through the National Disaster Medical System, to provide for certain laboratory reimbursement for
diagnostic testing for COVID-19 in uninsured individuals.
Sponsor: Rep. Tony Cardenas (D-CA-29)

H.R. 6231 - 116th Congress - Second Session
Ensuring Access to COVID-19 Preventive Care Act of 2020
Sponsor: Rep. Larry Bucshon (R-IN-08)

H.R. 6244 - 116th Congress - Second Session
To amend titles XVIII and XIX to provide for coverage at no cost sharing of COVID-19 testing under the Medicaid program and Children's Health
Insurance Program.
Sponsor: Rep. Robin Kelly (D-IL-02)

H.R. 6263 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to waive cost sharing under the Medicare program for certain visits relating to testing for COVID-19.
Sponsor: Rep. John Sarbanes (D-MD-03)


17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Mike
Warfel
​
​
Greg
Englert
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Health Insurance Tax (HIT Tax); Cadillac Tax; COVID-19 payroll tax

H.R.748 - 116th Congress
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.

H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Mike
Warfel
​
​
Greg
Englert
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicare Advantage; Rate Notice and Call Letter; Medicare Part D; Part D Rx Rebates; Medicare prescription drug prices, Generic drugs (CREATES), drug approval, Prior Authorization

S.3013 - 116th Congress (2019-2020)
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Sponsor: Sen. Toomey, Pat [R-PA]

H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]

H.R.3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Rep. Suzan DelBene (D-WA-01)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Mike
Warfel
​
​
Greg
Englert
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)